CEO
Pentaomix
The startup develops precision medicine technology that profiles multiple biomarkers at the cellular level to characterize tumor microenvironments while preserving localization context and morphology. This approach provides pathologists and oncologists with clinically relevant information to enhance diagnosis, prognosis, and predict drug response.
- Biotechnology
- Healthcare Technology
Updated 6 months ago
Funding
Raised to date
$270KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops precision medicine technology that profiles multiple biomarkers at the cellular level to characterize tumor microenvironments while preserving localization context and morphology. This approach provides pathologists and oncologists with clinically relevant information to enhance diagnosis, prognosis, and predict drug response.